ABOUT THE 13th ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM
Back for its 13th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2020 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors. The forum also features keynote speeches by KOL, about 60 selected corporate presentations from established (public and private) and emerging biotech's seeking to promote investment and partnering opportunities, and 20+ pitches by seed companies and during our Rising Stars session. We expect over 350 delegates to attend the event. The forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We anticipate more than 1700 face-to-face meetings to take place throughout 2 days.
Lori Badura, VP, Head of BD Neurology and Immunology - Global Business Development and Alliance Management, EMD Serono
Lubor Gaal, SVP, Head of Europe, Locust Walk
Mai-Britt Zocca, Founder & CEO, IO Biotech ApS
Mark Altmeyer, Founder & CEO, Arvelle Therapeutics
Matthias Müllenbeck, Executive Director & Head Global Licensing & BD Enabling Technologies, Merck KGaA
Michael Altorfer, CEO, Swiss Biotech Association
Mirko Scherer, CEO, CoFeS China Ltd.
Nathalie ter Wengel, European Lead, Worldwide Business Development, Pfizer, Inc.
Nicholas Franco, EVP & Chief Business Development Officer & Business Development and Strategic Planning, Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
Patric Gresko, Head of Division, Innovation and Technology Investment, EIF
Rachel Haurwitz, CEO, Caribou Biosciences, Inc.
Reagan Jarvis, CEO, Anocca AB
Sarah Holland, Global Head of Licensing, Lonza AG
Thibaut Roulon, Investment Director, Life Sciences Investments, Bpifrance
Thilo Schroeder, Partner, Nextech Invest Ltd.
Tim Luker, VP, Emerging Technology & Innovation, Corporate Business Development, Eli Lilly and Company
William Rice, Chairman, CEO & President, Aptose Biosciences, Inc.
Yochi Slonim, Co-Founder & CEO, Anima Biotech, Inc.
Yuwen Liu, Founding Partner, BOHE Angel Fund
More TBA shortly...
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Presenters at the 12th ELSCEO Forum Included:
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 13th Annual European Life Sciences CEO Forum is an effective way to gain leads, introduce new products and services, expand sales, and build relationships. Exhibition space is very limited - express your interest to secure the area.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
SILVER SPONSORS IN 2019:
SUPPORTED BY IN 2019:
PARTICIPATING PHARMAS IN 2019:
FINANCIAL, ADVISORY, INVESTORS IN 2019: AbbVie Ventures Abingworth LLP ACXIT Capital Management GmbH aescuvest international GmbH Alpha Omega LLC Andera Partners Arix Bioscience Plc. Avego Healthcare Capital Bay City Capital, LLC BB Biotech Ventures BERNINA BioInvest Ltd BioBac BioValley Basel Business Angels Club BioMedPartners AG BioSeed Capital BioStart Consulting GmbH Böhler Life Science